{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:55:35Z","timestamp":1791197735560,"version":"4.1.0"},"reference-count":60,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["80-83900-98-20013"],"award-info":[{"award-number":["80-83900-98-20013"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Telemedicine, the provision of remote healthcare, has gained prominence, accelerated by the COVID-19 pandemic. It has the potential to replace routine in-person follow-up visits for patients with chronic inflammatory skin conditions. However, it remains unclear whether telemedicine can effectively substitute in-person consultations for this patient group. This systematic review assessed the effectiveness and safety of telemedicine compared with traditional in-person care for chronic inflammatory skin diseases. A comprehensive search in various databases identified 11 articles, including 5 randomized controlled trials (RCTs) and 1 clinical controlled trial (CCT). These studies evaluated telemedicine\u2019s impact on patients with psoriasis and atopic dermatitis, with varying methods like video consultations and digital platforms. The findings tentatively suggest that telemedicine does not seem to be inferior compared with in-person care, particularly in terms of condition severity and quality of life for patients with chronic inflammatory skin diseases. However, these results should be interpreted with caution due to the inherent uncertainties in the evidence. There are indications that telemedicine can offer benefits such as cost-effectiveness, time savings, and reduced travel distances, but it is important to recognize these findings as preliminary, necessitating further validation through more extensive research.<\/jats:p>","DOI":"10.2340\/actadv.v104.23901","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T02:10:00Z","timestamp":1715825400000},"page":"adv23901","source":"Crossref","is-referenced-by-count":13,"title":["Is Telemedicine Suitable for Patients with Chronic Inflammatory Skin Conditions? A Systematic Review"],"prefix":"10.2340","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2679-5844","authenticated-orcid":false,"given":"Wynanda A.","family":"Van Enst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Chao","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie A. C.","family":"Wanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0516-8294","authenticated-orcid":false,"given":"Marieke M.B.","family":"Seyger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewout M.","family":"Baerveldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6884-8014","authenticated-orcid":false,"given":"Bernd W.M.","family":"Arents","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-5704","authenticated-orcid":false,"given":"Elke M.G.J.","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3642-2673","authenticated-orcid":false,"given":"Juul M.P.A.","family":"Van den Reek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"60876","doi-asserted-by":"crossref","unstructured":"Trettel A, Eissing L, Augustin M. Telemedicine in dermatology: findings and experiences worldwide - a systematic literature review. J Eur Acad Dermatol Venereol 2018; 32: 215-224.","DOI":"10.1111\/jdv.14341"},{"key":"60877","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.14341","DOI":"10.1111\/jdv.14341"},{"key":"60878","doi-asserted-by":"crossref","unstructured":"Lee JJ, English JC. Teledermatology: a review and update. Am J Clin Dermatol 2018; 19: 253-260.","DOI":"10.1007\/s40257-017-0317-6"},{"key":"60879","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s40257-017-0317-6","DOI":"10.1007\/s40257-017-0317-6"},{"key":"60880","doi-asserted-by":"crossref","unstructured":"Elsner P. Teledermatology in the times of COVID-19: a systematic review. J Dtsch Dermatol Ges 2020; 18: 841-845.","DOI":"10.1111\/ddg.14180"},{"key":"60881","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/ddg.14180","DOI":"10.1111\/ddg.14180"},{"key":"60882","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 2020; 323: 1945-1960.","DOI":"10.1001\/jama.2020.4006"},{"key":"60883","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jama.2020.4006","DOI":"10.1001\/jama.2020.4006"},{"key":"60884","doi-asserted-by":"crossref","unstructured":"St\u00e4nder S. Atopic dermatitis. N Engl J Med 2021; 384: 1136-1143.","DOI":"10.1056\/NEJMra2023911"},{"key":"60885","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMra2023911","DOI":"10.1056\/NEJMra2023911"},{"key":"60886","doi-asserted-by":"crossref","unstructured":"Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol 2019; 80: 1029-1072.","DOI":"10.1016\/j.jaad.2018.11.057"},{"key":"60887","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2018.11.057","DOI":"10.1016\/j.jaad.2018.11.057"},{"key":"60888","doi-asserted-by":"crossref","unstructured":"Marasca C, Annunziata MC, Camela E, Di Guida A, Fornaro L, Megna M, et al. Teledermatology and inflammatory skin conditions during COVID-19 era: new perspectives and applications. J Clin Med 2022; 11: 1511.","DOI":"10.3390\/jcm11061511"},{"key":"60889","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/jcm11061511","DOI":"10.3390\/jcm11061511"},{"key":"60890","doi-asserted-by":"crossref","unstructured":"Snoswell C, Finnane A, Janda M, Soyer HP, Whitty JA. Cost-effectiveness of store-and-forward teledermatology: a systematic review. JAMA Dermatol 2016; 152: 702-708.","DOI":"10.1001\/jamadermatol.2016.0525"},{"key":"60891","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamadermatol.2016.0525","DOI":"10.1001\/jamadermatol.2016.0525"},{"key":"60892","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Liria R, Valverde-Mart\u00ednez M\u00c1, L\u00f3pez-Villegas A, Bautista-Mesa RJ, Vega-Ram\u00edrez FA, Peir\u00f3 S, et al. Teledermatology versus face-to-face dermatology: an analysis of cost-effectiveness from eight studies from Europe and the United States. Int J Environ Res Public Health 2022; 19: 2534.","DOI":"10.3390\/ijerph19052534"},{"key":"60893","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/ijerph19052534","DOI":"10.3390\/ijerph19052534"},{"key":"60894","doi-asserted-by":"crossref","unstructured":"Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 2018; 32: 657-682.","DOI":"10.1111\/jdv.14891"},{"key":"60895","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.14891","DOI":"10.1111\/jdv.14891"},{"key":"60896","doi-asserted-by":"crossref","unstructured":"Nast A, Spuls PI, van der Kraaij G, Gisondi P, Paul C, Ormerod AD, et al. European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol 2017; 31: 1951-1963.","DOI":"10.1111\/jdv.14454"},{"key":"60897","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.14454","DOI":"10.1111\/jdv.14454"},{"key":"60898","doi-asserted-by":"crossref","unstructured":"El Komy MHM, Chiricozzi A, van de Kerkhof P, Armstrong A, Diamei V, Hsu C, et al. Telemedicine and psoriasis: a review based on statements of the telemedicine working group of the International Psoriasis Council. JEADV Clin Practice 2023; 2: 19-31.","DOI":"10.1002\/jvc2.93"},{"key":"60899","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/jvc2.93","DOI":"10.1002\/jvc2.93"},{"key":"60900","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.","DOI":"10.1136\/bmj.n71"},{"key":"60901","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"60902","doi-asserted-by":"crossref","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: 4898.","DOI":"10.1136\/bmj.l4898"},{"key":"60903","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"60904","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926.","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"60905","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"60906","doi-asserted-by":"crossref","unstructured":"Van Os-Medendorp H, Koffijberg H, Eland-De Kok PCM, Van Der Zalm A, De Bruin-Weller MS, Pasmans SGMA, et al. E-health in caring for patients with atopic dermatitis: a randomized controlled cost-effectiveness study of internet-guided monitoring and online self-management training. Br J Dermatol 2012; 166: 1060-1068.","DOI":"10.1111\/j.1365-2133.2012.10829.x"},{"key":"60907","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10829.x","DOI":"10.1111\/j.1365-2133.2012.10829.x"},{"key":"60908","doi-asserted-by":"crossref","unstructured":"Parsi K, Chambers CJ, Armstrong AW. Cost-effectiveness analysis of a patient-centered care model for management of psoriasis. J Am Acad Dermatol 2012; 66: 563-570.","DOI":"10.1016\/j.jaad.2011.02.022"},{"key":"60909","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2011.02.022","DOI":"10.1016\/j.jaad.2011.02.022"},{"key":"60910","doi-asserted-by":"crossref","unstructured":"Chambers CJ, Parsi KK, Schupp C, Armstrong AW. Patient-centered online management of psoriasis: a randomized controlled equivalency trial. J Am Acad Dermatol 2012; 66: 948-953.","DOI":"10.1016\/j.jaad.2011.05.047"},{"key":"60911","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2011.05.047","DOI":"10.1016\/j.jaad.2011.05.047"},{"key":"60912","doi-asserted-by":"crossref","unstructured":"Bergmo TS, Wangberg SC, Schopf TR, Solvoll T. Web-based consultations for parents of children with atopic dermatitis: results of a randomized controlled trial. Acta Paediatr 2009; 98: 316-320.","DOI":"10.1111\/j.1651-2227.2008.01033.x"},{"key":"60913","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1651-2227.2008.01033.x","DOI":"10.1111\/j.1651-2227.2008.01033.x"},{"key":"60914","doi-asserted-by":"crossref","unstructured":"Ford AR, Gibbons CM, Torres J, Kornmehl HA, Singh S, Young PM, et al. Access to dermatological care with an innovative online model for psoriasis management: results from a randomized controlled trial. Telemed J E Health 2019; 25: 619-627.","DOI":"10.1089\/tmj.2018.0160"},{"key":"60915","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1089\/tmj.2018.0160","DOI":"10.1089\/tmj.2018.0160"},{"key":"60916","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Chambers CJ, Maverakis E, Cheng MY, Dunnick CA, Chren MM, et al. Effectiveness of online vs in-person care for adults with psoriasis: a randomized clinical trial. JAMA Netw Open 2018; 1: e183062.","DOI":"10.1001\/jamanetworkopen.2018.3062"},{"key":"60917","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.3062","DOI":"10.1001\/jamanetworkopen.2018.3062"},{"key":"60918","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Johnson MA, Lin S, Maverakis E, Fazel N, Liu FT. Patient-centered, direct-access online care for management of atopic dermatitis: a randomized clinical trial. JAMA Dermatol 2015; 151: 154-160.","DOI":"10.1001\/jamadermatol.2014.2299"},{"key":"60919","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamadermatol.2014.2299","DOI":"10.1001\/jamadermatol.2014.2299"},{"key":"60920","doi-asserted-by":"crossref","unstructured":"Kornmehl H, Singh S, Johnson MA, Armstrong AW. Direct-access online care for the management of atopic dermatitis: a randomized clinical trial examining patient quality of life. Telemed J E Health 2017; 23: 726-732.","DOI":"10.1089\/tmj.2016.0249"},{"key":"60921","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1089\/tmj.2016.0249","DOI":"10.1089\/tmj.2016.0249"},{"key":"60922","doi-asserted-by":"crossref","unstructured":"Young PM, Chen AY, Ford AR, Cheng MY, Lane CJ, Armstrong AW. Effects of online care on functional and psychological outcomes in patients with psoriasis: a randomized controlled trial. J Am Acad Dermatol 2023; 88: 364-370.","DOI":"10.1016\/j.jaad.2019.05.089"},{"key":"60923","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2019.05.089","DOI":"10.1016\/j.jaad.2019.05.089"},{"key":"60924","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Ford AR, Chambers CJ, Maverakis E, Dunnick CA, Chren MM, et al. Online Care Versus In-Person Care for Improving Quality of Life in Psoriasis: A Randomized Controlled Equivalency Trial. J Invest Dermatol 2019; 139: 1037-1044.","DOI":"10.1016\/j.jid.2018.09.039"},{"key":"60925","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jid.2018.09.039","DOI":"10.1016\/j.jid.2018.09.039"},{"key":"60926","doi-asserted-by":"crossref","unstructured":"Oostveen AM, Beulens CA, Van De Kerkhof PCM, De Jong EMGJ, Seyger MMB. The effectiveness and safety of short-contact dithranol therapy in paediatric psoriasis: a prospective comparison of regular day care and day care with telemedicine. Br J Dermatol 2014; 170: 454-457.","DOI":"10.1111\/bjd.12621"},{"key":"60927","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.12621","DOI":"10.1111\/bjd.12621"},{"key":"60928","doi-asserted-by":"crossref","unstructured":"Kohn LL, Pickett K, Day JA, Torres-Zegarra C, Plost G, Gurnee E, et al. When is synchronous telehealth acceptable for pediatric dermatology? Pediatr Dermatol 2022; 39: 236-242.","DOI":"10.1111\/pde.14919"},{"key":"60929","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/pde.14919","DOI":"10.1111\/pde.14919"},{"key":"60930","doi-asserted-by":"crossref","unstructured":"Mossfeldt Nickelsen NC. The infrastructure of telecare: implications for nursing tasks and the nurse-doctor relationship. Sociol Health Illn 2019; 41: 67-80.","DOI":"10.1111\/1467-9566.12781"},{"key":"60931","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/1467-9566.12781","DOI":"10.1111\/1467-9566.12781"},{"key":"60932","doi-asserted-by":"crossref","unstructured":"Vittrup I, Andersen YMF, Skov L, Wu JJ, Agner T, Thomsen SF, et al. The association between atopic dermatitis, cognitive function and school performance in children and young adults. Br J Dermatol 2023; 188: 341-349","DOI":"10.1093\/bjd\/ljac058"},{"key":"60933","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/bjd\/ljac058","DOI":"10.1093\/bjd\/ljac058"},{"key":"60934","doi-asserted-by":"crossref","unstructured":"Benedetto V, Filipe L, Harris C, Spencer J, Hickson C, Clegg A. Analytical frameworks and outcome measures in economic evaluations of digital health interventions: a methodological systematic review. Med Decis Making 2023; 43: 125-138.","DOI":"10.1177\/0272989X221132741"},{"key":"60935","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/0272989X221132741","DOI":"10.1177\/0272989X221132741"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/23901\/46175","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/23901\/46175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T02:10:35Z","timestamp":1715825435000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/23901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":60,"URL":"https:\/\/doi.org\/10.2340\/actadv.v104.23901","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,15]]}}}